M&A / Deals Biogen to acquire RayThera for up to $1bn Pharmaceutical Business ReviewThe deal value comprises an upfront payment and further payments tied to the achievement of future clinical and regulatory milestones.NeuroscienceRead full story pharminent June 19, 2026 (Last updated: June 19, 2026) Pharmaceutical Business Review The deal value comprises an upfront payment and further payments tied to the achievement of future clinical and regulatory milestones. Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Previous Post Related Stories M&A / Deals Heart drug biotech Kardigan raises $400m in upscaled IPO pharminent June 18, 2026 M&A / Deals Cardio biotech Kardigan binds off $400M upsized IPO pharminent June 18, 2026 M&A / Deals LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs pharminent June 18, 2026
